RAS Inhibitors Show Promise for CLTI Patients After Interventions
LONG-TERM MORTALITY BENEFIT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA UNDERGOING VASCULAR INTERVENTION, Journal of Vascular Surgery, March 2018
CHICAGO, Illinois, Feb. 26, 2018 – Physicians should consider prescribing high-dose angiotensin inhibitors for patients with chronic limb-threatening ischemia (CLTI), a recent study from Harvard University suggests.